Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer

NCT00130520 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Neoplasms

Interventions

DRUG: bevacizumab
DRUG: erlotinib

Sponsor

University of Arizona

Collaborators

[object Object]